Jobbet Product Manager Nordics har sparats.


Redo att ansöka?

Vänligen bekräfta din mailadress för att starta din ansökan.
För information om hur vi hanterar dina personuppgifter, se vår Sekretesspolicy.

Jobb sparad

Ange din e-postadress för att spara det här jobbet

Du sparar detta jobb som:


Gör klar din ansökan

Logga in

glömt lösenord?

Har du inte ett konto?

7 ansökningar


Product Manager Nordics to Italian pharma company based in Kista!

Your new role
On the behalf of our client Recordati, Hays is seeking a Product Manager Nordics to join their team in Kista, Stockholm. This is for a brand new team and you will be part of growing the organisation in the Nordic region. You will report directly to the General Manager Nordics & Baltics who is based in the Stockholm office.

The Product Manager Nordics will support development of Brand Strategies and drive implementation in accordance with corporate brand guidelines (adapted to national market requirements). You will prepare brand related tools for the sales organization to be used in interaction with customers as well as being responsible for the development of operational marketing tools.

The main focus to start with will be on the launch of Reagila in September 2018 and continued development and sales for their product Recordati Gastro portfolio. You will be responsible for market analysis, forecasting, compliance and input to the brand plan. Further you will be building and maintaining the good relationships with key opinion leaders, patient associations and healthcare organisations, to ensure monitoring of potential performance improvement in the field.

What you'll need to succeed
You have a relevant degree and minimum of 5 years of experience from the pharmaceutical industry. You have relevant up-to-date knowledge of laws, regulations and industry standards. You have excellent communications skills and the ability to build strong and valuable relationships with relevant external key stakeholders and organisations. Further you have the experience of taking lead, work independently and drive projects forward. The business language is English. Speaking Swedish is an advantage, as well as any of the other Nordic languages in addition.

What you'll get in return
You will be joining a growing team and be part of establishing Recordati business in the Nordic region from start. Our working environment is inspiring, fast and informal with knowledgably and experienced peers. You have an opportunity of influencing the commercial direction of the company and we are looking forward to a long-term collaboration in which you may further develop within the company What you need to do now In this recruitment Recordati is working with Hays Life Sciences. If you're interested in this role, then click here to forward an up-to-date copy of your CV and personal letter in one document. For inquiries regarding the position or process please contact the responsible recruitment consultant Johanna Alderin, Selection of candidates will be carried out continuously, so be sure to send in your application as soon as possible.

Your new company
Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,100, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2017 was € 1,288.1 million, operating income was € 406.5 million and net income was € 288.8 million.



Skriv in din e-postadress så skickar vi dig liknande jobb som detta.

Tack! Vi skickar jobb som liknar detta till